Related Experiment Video
Updated: May 9, 2026
10:33
Primed Mycobacterial Uveitis (PMU) as a Model for Post-Infectious Uveitis
Published on: December 17, 2021
Pediatric uveitis: new and future treatments
Preema J Mehta1, Janet L Alexander, H Nida Sen
1National Eye Institute/National Institutes of Health, Bethesda, Maryland 20892, USA.
Current Opinion in Ophthalmology
|July 23, 2013
Summary
Pediatric uveitis, though rare, poses significant challenges due to complications. Current immunomodulatory therapies offer benefits but are limited by side effects, necessitating exploration of novel treatments for this complex condition.
Area of Science:
- Ophthalmology
- Pediatric Rheumatology
- Immunology
Background:
- Pediatric uveitis accounts for 5-10% of all uveitis cases.
- It carries a significant lifetime burden due to complications and severe outcomes.
- Noninfectious pediatric uveitis often requires long-term management.
Purpose of the Study:
- To review current therapies for pediatric uveitis.
- To discuss novel and emerging treatment options.
- To provide clinical recommendations for managing pediatric uveitis.
Main Methods:
- Literature review of existing and emerging treatments for pediatric uveitis.
- Analysis of immunomodulatory therapy outcomes and limitations.
- Synthesis of clinical recommendations based on current evidence.
Main Results:
- Immunomodulatory therapy is linked to improved outcomes in noninfectious pediatric uveitis.
- Effective treatments are often hindered by medication-related complications, including organ toxicities.
- A multifactorial approach is crucial for selecting treatment regimens.
Conclusions:
- Understanding the evolution of treatment technologies is vital for managing pediatric uveitis.
- Novel therapeutic agents are crucial for addressing the complexities of this disease.
- Future strategies should integrate past, present, and future therapeutic advancements.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.